Viewing Study NCT04909034


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-26 @ 7:00 PM
Study NCT ID: NCT04909034
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2021-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Sponsor: Microbio Co Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module